Risk factors associated with alterations in carotid intima—media thickness in hypertension
Authors:
- Alberto ZanchettiAZAlberto Zanchetti
- M Gene BondMBM Gene Bond
- Michael HennigMHMichael Hennig
- Albrecht NeissANAlbrecht Neiss
- Giuseppe ManciaGMGiuseppe Mancia
- Cesare Dal PalùCPCesare Dal Palù
- Lennart HanssonLHLennart Hansson
- Bruno MagnaniBMBruno Magnani
- Karl-Heinz RahnKRKarl-Heinz Rahn
- John ReidJRJohn Reid
- Josè RodicioJRJosè Rodicio
- Michel SafarMSMichel Safar
- 1 July 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 16 (7) , 949-961
Abstract
The possibility that calcium antagonists exert an anti-atherosclerotic action at least partly independently of the blood-pressure-lowering effect is supported by results of a large number of experimental studies and can now be investigated by quantitative β-mode ultrasound imagining of the carotid artery walls. The European Lacidipine Study on Atherosclerosis (ELSA) is a prospective, randomized, double-blind, multinational trial comparing effects of 4-year treatment based on the long-acting, highly lipophilic calcium antagonist lacidipine with those of treatment based on the β-blocker atenolol on the development of carotid artery wall alterations in patients (aged 45–75 years) with mild-to-moderate hypertension (systolic blood pressure 150–210 mmHg and diastolic blood pressure 95–115 mmHg). While the intervention study is progressing, this article summarizes baseline data obtained from the whole cohort of 2259 patients randomly allocated to treatment. Baseline ultrasound data were obtained from two replicate examinations performed shortly before random allocation to treatment by certified sonographers at 23 referral centres and read at the ultrasound coordinating centre at the Wake Forest University School of Medicine. Intima—media thickness was measured at up to 12 different sites in the carotid artery tree and expressed as the mean of the maxima at these sites (Mmax), the mean of the maxima at four sites in the distal common carotid artery and bifurcation (CBMmax) and the maximum intima—media thickness (Tmax). Baseline demographic and clinical measurements were performed by investigators in 410 peripheral clinical units and 24 h ambulatory blood pressure monitorings read and validated by members of a centralized unit at the University of Milan. The statistical analysis centre at the Technische Universität Mächen received and analysed all baseline data, by calculating means ± SD, medians and ranges and performing correlation (Spearman correlation coefficients) and multiple regression analyses. Prevalence of carotid artery wall alterations among the hypertensive patients randomly allocated to treatment in the ELSA was very high: 82% had Tmax > 1.3 mm (‘plaques’ according to protocol) and 17% had Tmax > 1.0 and < 1.3 mm (‘thickening’), with a median of two plaques per patient. We found significant correlations between ultrasound measurements and the following demographic and clinical variables: age, sex, systolic blood pressure and pulse pressure (both clinic and ambulatory), concentrations of total, high-density lipoprotein and low-density lipoprotein cholesterol and triglycerides, smoking habit and duration of hypertension. We found no significant correlation to diastolic blood pressure and glucose concentration. A multiple regression analysis indicated significant variables in the following rank order: age, 24 h ambulatory pulse pressure, sex, low-density lipoprotein cholesterol concentration, triglyceride concentration, smoking and clinic systolic blood pressure. Analysis of baseline data from the ELSA has shown that there is an extremely marked prevalence of carotid artery wall alterations among mild-to-moderate, middle-aged hypertensive patients. In addition to age, systolic blood pressure and pulse pressure, particularly if they are accurately measured by ambulatory monitoring, play a major role, somewhat greater than those of sex, low-density lipoprotein cholesterol concentration and smoking, in influencing intima—media thickness.Keywords
This publication has 32 references indexed in Scilit:
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial1996
- Trials investigating the anti-atherosclerotic effects of antihypertensive drugsJournal Of Hypertension, 1996
- Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA)Journal Of Hypertension, 1995
- Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart diseaseBritish Medical Bulletin, 1994
- Measurement of the ultrasonic intima-media complex thickness in normal subjectsJournal of Vascular Surgery, 1993
- Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group.Stroke, 1992
- The Antiatherogenic Effects of Antihypertensive Drugs: Experimental and Clinical EvidenceClinical and Experimental Hypertension. Part A: Theory and Practice, 1992
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Detection and monitoring of asymptomatic atherosclerosis in clinical trialsThe American Journal of Medicine, 1989